Antiseptic Log Reduction Criteria Should Stand, NDAC Recommends
This article was originally published in The Rose Sheet
Executive Summary
Current log reduction criteria to measure the efficacy of topical antiseptic products should not be reduced due to a lack of "compelling" data to support revising the standards, FDA's Nonprescription Drugs Advisory Committee concluded during a March 23 meeting in Gaithersburg, Md
You may also be interested in...
NDAC To Assess Risks, Efficacy Of Antiseptic Hand Wash Products
The risks and benefits of consumer antibacterial hand and body wash products will be considered by the Center for Drug Evaluation & Research Nonprescription Drugs Advisory Committee at a meeting slated for Oct. 20-21
NDAC To Assess Risks, Efficacy Of Antiseptic Hand Wash Products
The risks and benefits of consumer antibacterial hand and body wash products will be considered by the Center for Drug Evaluation & Research Nonprescription Drugs Advisory Committee at a meeting slated for Oct. 20-21
Triclocarban 1.5% Category I Antimicrobial Status Sought By P&G
FDA should include triclocarban at levels of up to 1.5% as a Category I ingredient in its OTC topical antimicrobial products final monograph, Procter & Gamble states in Aug. 19 comments to the agency